Cargando…

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay

For many years, oncological clinical trials have taken advantage of dendritic cells (DC) for the design of DC-based cellular therapies. This has required the design of suitable quality control assays to evaluate the potency of these products. The purpose of our work was to develop and validate a nov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carloni, Silvia, Piccinini, Claudia, Pancisi, Elena, Soldati, Valentina, Stefanelli, Monica, Granato, Anna Maria, Ibrahim, Toni, Petrini, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198694/ https://www.ncbi.nlm.nih.gov/pubmed/34072360 http://dx.doi.org/10.3390/ijms22115824

Ejemplares similares

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
por: Pancisi, Elena, et al.
Publicado: (2022)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
por: Ridolfi, Laura, et al.
Publicado: (2018)

Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
por: Bulgarelli, Jenny, et al.
Publicado: (2019)

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
por: de Rosa, Francesco, et al.
Publicado: (2014)

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
por: Ridolfi, Laura, et al.
Publicado: (2010)

Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”
por: Ridolfi, Laura, et al.
Publicado: (2011)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
por: Ridolfi, Ruggero, et al.
Publicado: (2006)

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients
por: Ridolfi, Laura, et al.
Publicado: (2013)

Evaluation of in vivo labelled dendritic cell migration in cancer patients
por: Ridolfi, Ruggero, et al.
Publicado: (2004)

Anticancer metallohelices: nanomolar potency and high selectivity
por: Kaner, Rebecca A., et al.
Publicado: (2016)

Assaying the Potency of Influenza Vaccines
por: Minor, Philip D.
Publicado: (2015)

MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia
por: Zhong, Guocheng, et al.
Publicado: (2022)

Enhancing Potency and Selectivity of a DC‐SIGN Glycomimetic Ligand by Fragment‐Based Design: Structural Basis
por: Medve, Laura, et al.
Publicado: (2019)

Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines
por: Chang, Wei-Ting, et al.
Publicado: (2013)

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
por: Dudek, Aleksandra M., et al.
Publicado: (2013)

In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes
por: Abyar, Selda, et al.
Publicado: (2019)

Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC
por: Schierer, Stefan, et al.
Publicado: (2018)

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
por: Bulgarelli, Jenny, et al.
Publicado: (2021)

Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
por: Surenaud, Mathieu, et al.
Publicado: (2019)

Bananas decrease acetaminophen potency in in vitro assays
por: Uesawa, Yoshihiro, et al.
Publicado: (2018)

Thiopurines Analogues with Additional Ring: Synthesis, Spectroscopic Properties, and Anticancer Potency
por: Krancewicz, Katarzyna, et al.
Publicado: (2023)

Potency assays and biomarkers for cell-based advanced therapy medicinal products
por: Capelli, Chiara, et al.
Publicado: (2023)

ADCC potency assay: increased standardization with modified lymphocytes
por: Bretaudeau, Laurent, et al.
Publicado: (2011)

Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell
por: Hansen, Stine Bangsgaard, et al.
Publicado: (2022)

Biological Assay to Determine Gonadotropin Potency: From In Vivo to In Vitro Sustainable Method
por: Nevelli, Francesco, et al.
Publicado: (2023)

Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus
por: Johnson, Teresa R., et al.
Publicado: (2011)

Stemness Potency of Human Gingival Cells—Application in Anticancer Therapies and Clinical Trials
por: Stefańska, Katarzyna, et al.
Publicado: (2020)

LingZhi oligopeptides amino acid sequence analysis and anticancer potency evaluation
por: Liu, Jie, et al.
Publicado: (2020)

In vivo Study of Chalcone Loaded Carbon Dots for Enhancement of Anticancer and Bioimaging Potencies
por: Fahmi, Mochamad Zakki, et al.
Publicado: (2023)

Surrogate potency assays: Comparison of binding profiles complements dose response curves for unambiguous assessment of relative potencies
por: Karlsson, Robert, et al.
Publicado: (2018)

Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
por: Geijtenbeek, Teunis B.H., et al.
Publicado: (2003)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Potency analysis of cellular therapies: the emerging role of molecular assays
por: Stroncek, David F, et al.
Publicado: (2007)

Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay.
por: Milligan, S R, et al.
Publicado: (1998)

Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder
por: Tótoli, Eliane Gandolpho, et al.
Publicado: (2015)

Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
por: Rosen, Osnat, et al.
Publicado: (2016)

Therapeutic potency of fermented field water-dropwort (Oenanthe javanica (Blume) DC.) in ethanol-induced liver injury
por: Lee, Dong Hun, et al.
Publicado: (2020)

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency
por: Zhang, Yi, et al.
Publicado: (2014)

Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC
por: Baek, Soyoung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dse859p735474uj6talk2llu09